These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

666 related items for PubMed ID: 26073023

  • 21. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.
    Wang H, Shimosawa T, Matsui H, Kaneko T, Ogura S, Uetake Y, Takenaka K, Yatomi Y, Fujita T.
    J Hypertens; 2008 Jul; 26(7):1453-62. PubMed ID: 18551023
    [Abstract] [Full Text] [Related]

  • 22. Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis.
    Ye P, Yamashita T, Pollock DM, Sasano H, Rainey WE.
    Horm Metab Res; 2009 Jan; 41(1):35-9. PubMed ID: 18819053
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Activation of mineralocorticoid receptors in the rostral ventrolateral medulla is involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats.
    Nakagaki T, Hirooka Y, Matsukawa R, Nishihara M, Nakano M, Ito K, Hoka S, Sunagawa K.
    Hypertens Res; 2012 Apr; 35(4):470-6. PubMed ID: 22237482
    [Abstract] [Full Text] [Related]

  • 31. Mineralocorticoid receptor antagonists, a class beyond spironolactone--Focus on the special pharmacologic properties of eplerenone.
    Seferovic PM, Pelliccia F, Zivkovic I, Ristic A, Lalic N, Seferovic J, Simeunovic D, Milinkovic I, Rosano G.
    Int J Cardiol; 2015 Dec 01; 200():3-7. PubMed ID: 26404746
    [Abstract] [Full Text] [Related]

  • 32. Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists.
    Hasui T, Ohyabu N, Ohra T, Fuji K, Sugimoto T, Fujimoto J, Asano K, Oosawa M, Shiotani S, Nishigaki N, Kusumoto K, Matsui H, Mizukami A, Habuka N, Sogabe S, Endo S, Ono M, Siedem CS, Tang TP, Gauthier C, De Meese LA, Boyd SA, Fukumoto S.
    Bioorg Med Chem; 2014 Oct 01; 22(19):5428-45. PubMed ID: 25187277
    [Abstract] [Full Text] [Related]

  • 33. Central mineralocorticoid receptors and the role of angiotensin II and glutamate in the paraventricular nucleus of rats with angiotensin II-induced hypertension.
    Gabor A, Leenen FH.
    Hypertension; 2013 May 01; 61(5):1083-90. PubMed ID: 23509081
    [Abstract] [Full Text] [Related]

  • 34. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.
    Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T.
    Hypertension; 2007 Feb 01; 49(2):355-64. PubMed ID: 17200434
    [Abstract] [Full Text] [Related]

  • 35. Recent studies with eplerenone, a novel selective aldosterone receptor antagonist.
    McMahon EG.
    Curr Opin Pharmacol; 2001 Apr 01; 1(2):190-6. PubMed ID: 11714095
    [Abstract] [Full Text] [Related]

  • 36. Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology.
    Delyani JA.
    Kidney Int; 2000 Apr 01; 57(4):1408-11. PubMed ID: 10760075
    [Abstract] [Full Text] [Related]

  • 37. Mineralocorticoid receptors/epithelial Na(+) channels in the choroid plexus are involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats.
    Nakano M, Hirooka Y, Matsukawa R, Ito K, Sunagawa K.
    Hypertens Res; 2013 Mar 01; 36(3):277-84. PubMed ID: 23096235
    [Abstract] [Full Text] [Related]

  • 38. Mechanisms in the PVN mediating local and central sodium-induced hypertension in Wistar rats.
    Gabor A, Leenen FH.
    Am J Physiol Regul Integr Comp Physiol; 2009 Mar 01; 296(3):R618-30. PubMed ID: 19109373
    [Abstract] [Full Text] [Related]

  • 39. Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats.
    Ohtake M, Hattori T, Murase T, Takahashi K, Takatsu M, Ohtake M, Miyachi M, Watanabe S, Cheng XW, Murohara T, Nagata K.
    Nagoya J Med Sci; 2014 Feb 01; 76(1-2):59-72. PubMed ID: 25129992
    [Abstract] [Full Text] [Related]

  • 40. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Nakagawa H, Oberwinkler H, Nikolaev VO, Gaßner B, Umbenhauer S, Wagner H, Saito Y, Baba HA, Frantz S, Kuhn M.
    Circ Heart Fail; 2014 Sep 01; 7(5):814-21. PubMed ID: 25027872
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.